Cargando…
Photosensitivity Reactions to Vandetanib: Redevelopment after Sequential Treatment with Docetaxel
Vandetanib (ZD6474, Zactima™) is a novel, orally available inhibitor of different intracellular signaling pathways involved in tumor growth, progression, and angiogenesis, including vascular endothelial growth factor receptor-2, epidermal growth factor receptor, and rearranged during transfection ty...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Dermatological Association; The Korean Society for Investigative Dermatology
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3276785/ https://www.ncbi.nlm.nih.gov/pubmed/22346266 http://dx.doi.org/10.5021/ad.2011.23.S3.S314 |